Annual report pursuant to Section 13 and 15(d)

Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details)

v3.19.1
Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details) - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Details    
Real estate note $ 111,843 $ 116,632
Working capital note 909,507 764,389
Note receivable discount (7,591) 0
Accrued interest 3,067 0
Note Receivable, Current and non-current portions 1,016,826 881,021
Less current portion (45,173) (35,445)
Long term portion of notes receivable $ 971,653 $ 845,576